Key Market Indicators
Sales of analgesic medicines in Costa Rica are estimated to hit $10.88 million by 2026. This is up from $9.02 million in 2021, representing an average annual growth of 3.6%. Since 2012, the Costa Rican market has grown by 13.5% per year. In 2021, it ranked 25th globally, with Iceland leading the way at $9.02 million. Spain, Canada, and Italy were the next three largest markets, respectively.